Gene Therapy: Can CDMOs Solve the Manufacturing Bottleneck?

The gene therapy market is booming. Viral vectors, the key delivery systems for gene therapies, are playing an increasing role in the development of biologics. But the growing need for viral vectors and their plasmid building blocks have resulted in a manufacturing bottleneck. Can contract…

Source: www.labiotech.eu – Read more